FDA Inspection 1190487 — Bausch Health Companies Inc.
The FDA completed an inspection of Bausch Health Companies Inc. on September 29, 2022 in Laval. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 29, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Laval (Canada)